首页> 外国专利> antigen-binding protein, and methods of neutralizing tyrosine kinase receptor activation, inhibiting angiogenesis, reducing tumor growth and producing an antigen-binding protein

antigen-binding protein, and methods of neutralizing tyrosine kinase receptor activation, inhibiting angiogenesis, reducing tumor growth and producing an antigen-binding protein

机译:抗原结合蛋白,以及中和酪氨酸激酶受体激活,抑制血管生成,减少肿瘤生长和产生抗原结合蛋白的方法

摘要

ANTIGEN BINDING PROTEIN AND METHODS FOR NEUTRALIZING THE ACTIVATION OF A THYROSINE KINASE RECEPTOR, ANGIOGENESIS INHIBITION, REDUCING TUMOR GROWTH ANTIBODIES AND UNDERSTANDING A ANTIGENE PROTEIN PROTECTION single domain link sites. Antibodies can be bivalent or multivalent, and can be bispecific. The invention is also directed to monospecific and bispecific antibodies, which bind to mPDGFR 244. Antibodies can be administered alone or in combination with antiangiogenic or antineoplastic drugs.
机译:抗原结合蛋白和用于酪氨酸激酶受体激活,血管生成抑制,减少肿瘤生长抗体和理解抗原蛋白保护单域链接位点的营养中和的方法。抗体可以是二价或多价的,并且可以是双特异性的。本发明还涉及与mPDGFR <244>结合的单特异性和双特异性抗体。抗体可以单独给药,也可以与抗血管生成或抗肿瘤药联合给药。

著录项

  • 公开/公告号BRPI0707824A2

    专利类型

  • 公开/公告日2011-05-10

    原文格式PDF

  • 申请/专利权人 IMCLONE SYSTEMS INCORPORATED;

    申请/专利号BR2007PI07824

  • 发明设计人 ZHENPING ZHU;

    申请日2007-02-15

  • 分类号A61K39;A61K39/395;C12P21/08;

  • 国家 BR

  • 入库时间 2022-08-21 18:07:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号